PTC Therapeutics, Inc. Capital Expenditures
PTC Therapeutics, Inc. (PTCT) reported Capital Expenditures of $3.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-07-30
- PTC Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $2.19M, a 75.78% increase year-over-year.
- PTC Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $1.20M, a 30.57% decline year-over-year.
- PTC Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $2.37M, a 36.98% decline year-over-year.
- PTC Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $3.52M, a 573.37% increase year-over-year.
- PTC Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $8.86M, a 36.27% increase from fiscal 2024.
- PTC Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $6.50M, a 77.14% decline from fiscal 2023.
- PTC Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $28.44M, a 11.18% decline from fiscal 2022.
- PTC Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $32.02M, a 13.48% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $3.39M 10-Q · filed 2026-07-30 | $5.76M derived: sum of 3 quarters · filed 2026-07-30 | $9.28M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2026-03-31 | $1.20M 10-Q · filed 2026-05-07 | $3.57M derived: sum of 2 quarters · filed 2026-05-07 | $7.09M derived: sum of 3 quarters · filed 2026-05-07 | $8.33M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $5.89M derived: sum of 2 quarters · filed 2026-02-19 | $7.14M derived: sum of 3 quarters · filed 2026-07-30 | $8.86M 10-K · filed 2026-02-19 | |||
| 2025-09-30 | $3.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $4.76M derived: sum of 2 quarters · filed 2026-07-30 | $6.49M 10-Q · filed 2025-11-04 | $10.25M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $2.97M 10-Q · filed 2026-07-30 | $3.04M 10-Q · filed 2025-08-07 | $6.74M derived: sum of 3 quarters · filed 2026-07-30 | $7.26M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $1.72M 10-Q · filed 2026-05-07 | $5.49M derived: sum of 2 quarters · filed 2026-05-07 | $6.01M derived: sum of 3 quarters · filed 2026-05-07 | -$1.36M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $4.29M derived: sum of 2 quarters · filed 2026-02-19 | -$3.09M derived: sum of 3 quarters · filed 2026-02-19 | $6.50M 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $522.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$6.85M derived: sum of 2 quarters · filed 2025-11-04 | $2.73M 10-Q · filed 2025-11-04 | $8.30M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-06-30 | -$7.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.21M 10-Q · filed 2025-08-07 | $7.78M derived: sum of 3 quarters · filed 2026-02-19 | $14.14M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-03-31 | $9.59M 10-Q · filed 2025-05-06 | $15.15M derived: sum of 2 quarters · filed 2026-02-19 | $21.51M derived: sum of 3 quarters · filed 2026-02-19 | $27.76M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2023-12-31 | $5.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $11.92M derived: sum of 2 quarters · filed 2026-02-19 | $18.17M derived: sum of 3 quarters · filed 2026-02-19 | $28.44M 10-K · filed 2026-02-19 | |||
| 2023-09-30 | $6.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $12.60M derived: sum of 2 quarters · filed 2024-11-07 | $22.87M 10-Q · filed 2024-11-07 | $31.49M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | $6.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $16.52M 10-Q · filed 2024-08-08 | $25.14M derived: sum of 3 quarters · filed 2025-02-27 | $30.52M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | $10.27M 10-Q · filed 2024-04-25 | $18.89M derived: sum of 2 quarters · filed 2025-02-27 | $24.27M derived: sum of 3 quarters · filed 2025-02-27 | $32.97M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $8.62M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $14.00M derived: sum of 2 quarters · filed 2025-02-27 | $22.70M derived: sum of 3 quarters · filed 2025-02-27 | $32.02M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $5.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $14.08M derived: sum of 2 quarters · filed 2023-10-26 | $23.39M 10-Q · filed 2023-10-26 | $32.12M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $8.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $18.01M 10-Q · filed 2023-08-03 | $26.74M derived: sum of 3 quarters · filed 2024-02-29 | $32.58M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | $9.31M 10-Q · filed 2023-04-27 | $18.04M derived: sum of 2 quarters · filed 2024-02-29 | $23.88M derived: sum of 3 quarters · filed 2024-02-29 | $31.86M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $8.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $14.57M derived: sum of 2 quarters · filed 2024-02-29 | $22.54M derived: sum of 3 quarters · filed 2024-02-29 | $28.21M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $5.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $13.82M derived: sum of 2 quarters · filed 2022-10-27 | $19.49M 10-Q · filed 2022-10-27 | $25.84M derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2021-06-30 | $7.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $13.64M 10-Q · filed 2022-08-04 | $20.00M derived: sum of 3 quarters · filed 2023-02-21 | $23.30M derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2021-03-31 | $5.67M 10-Q · filed 2022-05-03 | $12.02M derived: sum of 2 quarters · filed 2023-02-21 | $15.33M derived: sum of 3 quarters · filed 2023-02-21 | $17.49M derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2020-12-31 | $6.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $9.66M derived: sum of 2 quarters · filed 2023-02-21 | $11.82M derived: sum of 3 quarters · filed 2023-02-21 | $17.84M 10-K · filed 2023-02-21 | |||
| 2020-09-30 | $3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $5.47M derived: sum of 2 quarters · filed 2021-10-28 | $11.49M 10-Q · filed 2021-10-28 | $16.14M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-06-30 | $2.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $8.18M 10-Q · filed 2021-07-29 | $12.84M derived: sum of 3 quarters · filed 2022-02-22 | $17.09M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-03-31 | $6.02M 10-Q · filed 2021-05-04 | $10.68M derived: sum of 2 quarters · filed 2022-02-22 | $14.93M derived: sum of 3 quarters · filed 2022-02-22 | $16.91M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2019-12-31 | $4.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $8.91M derived: sum of 2 quarters · filed 2022-02-22 | $10.89M derived: sum of 3 quarters · filed 2022-02-22 | $13.76M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | $4.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $6.24M derived: sum of 2 quarters · filed 2020-10-29 | $9.10M 10-Q · filed 2020-10-29 | $13.71M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | $1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $4.85M 10-Q · filed 2020-08-05 | $9.46M derived: sum of 3 quarters · filed 2021-02-25 | $10.76M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | $2.87M 10-Q · filed 2020-04-30 | $7.47M derived: sum of 2 quarters · filed 2021-02-25 | $8.78M derived: sum of 3 quarters · filed 2021-02-25 | $9.48M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | $4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $5.91M derived: sum of 2 quarters · filed 2021-02-25 | $6.62M derived: sum of 3 quarters · filed 2021-02-25 | $7.10M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $2.01M derived: sum of 2 quarters · filed 2019-10-30 | $2.49M 10-Q · filed 2019-10-30 | $4.53M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $708.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $1.19M 10-Q · filed 2019-08-06 | $3.23M derived: sum of 3 quarters · filed 2020-03-02 | $3.71M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-03-31 | $479.00K 10-Q · filed 2019-05-02 | $2.52M derived: sum of 2 quarters · filed 2020-03-02 | $3.00M derived: sum of 3 quarters · filed 2020-03-02 | $3.35M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2017-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $2.52M derived: sum of 2 quarters · filed 2020-03-02 | $2.88M derived: sum of 3 quarters · filed 2020-03-02 | $3.10M 10-K · filed 2020-03-02 | |||
| 2017-09-30 | $479.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $833.00K derived: sum of 2 quarters · filed 2018-11-05 | $1.06M 10-Q · filed 2018-11-05 | $2.29M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-06-30 | $354.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $579.00K 10-Q · filed 2018-08-07 | $1.81M derived: sum of 3 quarters · filed 2019-03-01 | $2.08M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-03-31 | $225.00K 10-Q · filed 2018-05-09 | $1.46M derived: sum of 2 quarters · filed 2019-03-01 | $1.73M derived: sum of 3 quarters · filed 2019-03-01 | $1.74M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $1.50M derived: sum of 2 quarters · filed 2019-03-01 | $1.51M derived: sum of 3 quarters · filed 2019-03-01 | $1.78M 10-K · filed 2019-03-01 | |||
| 2016-09-30 | $265.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $275.00K derived: sum of 2 quarters · filed 2017-11-02 | $540.00K 10-Q · filed 2017-11-02 | $1.50M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $275.00K 10-Q · filed 2017-08-09 | $1.23M derived: sum of 3 quarters · filed 2018-03-06 | $1.82M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-03-31 | $265.00K 10-Q · filed 2017-05-08 | $1.22M derived: sum of 2 quarters · filed 2018-03-06 | $1.81M derived: sum of 3 quarters · filed 2018-03-06 | $2.10M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2015-12-31 | $956.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $1.54M derived: sum of 2 quarters · filed 2018-03-06 | $1.84M derived: sum of 3 quarters · filed 2018-03-06 | $2.72M 10-K · filed 2018-03-06 | |||
| 2015-09-30 | $587.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $881.00K derived: sum of 2 quarters · filed 2016-11-03 | $1.76M 10-Q · filed 2016-11-03 | $5.27M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | $294.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $1.18M 10-Q · filed 2016-08-04 | $4.68M derived: sum of 3 quarters · filed 2017-03-16 | $5.00M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | $883.00K 10-Q · filed 2016-05-05 | $4.39M derived: sum of 2 quarters · filed 2017-03-16 | $4.71M derived: sum of 3 quarters · filed 2017-03-16 | $5.36M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $3.51M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $3.83M derived: sum of 2 quarters · filed 2017-03-16 | $4.48M derived: sum of 3 quarters · filed 2017-03-16 | $4.66M 10-K · filed 2017-03-16 | |||
| 2014-09-30 | $319.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $970.00K derived: sum of 2 quarters · filed 2015-11-09 | $1.16M 10-Q · filed 2015-11-09 | $1.53M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $651.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $837.00K 10-Q · filed 2015-07-31 | $1.21M derived: sum of 3 quarters · filed 2016-02-29 | $1.59M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $186.00K 10-Q · filed 2015-05-05 | $558.00K derived: sum of 2 quarters · filed 2016-02-29 | $936.00K derived: sum of 3 quarters · filed 2016-02-29 | $1.01M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $372.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $750.00K derived: sum of 2 quarters · filed 2016-02-29 | $825.00K derived: sum of 3 quarters · filed 2016-02-29 | $846.00K 10-K · filed 2016-02-29 | $845.73K 10-K · filed 2014-03-06 | ||
| 2013-09-30 | $378.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $453.00K derived: sum of 2 quarters · filed 2014-11-06 | $474.00K 10-Q · filed 2014-11-06 | $473.77K 10-Q · filed 2013-11-14 | $479.49K derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-06-30 | $75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $96.00K 10-Q · filed 2014-08-07 | $95.79K 10-Q · filed 2013-08-13 | $101.49K derived: sum of 3 quarters · filed 2015-03-02 | $105.78K derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-03-31 | $21.00K 10-Q · filed 2014-05-06 | $26.49K derived: sum of 2 quarters · filed 2015-03-02 | $30.78K derived: sum of 3 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $5.49K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $9.78K derived: sum of 2 quarters · filed 2015-03-02 | $189.00K 10-K · filed 2015-03-02 | $188.68K 10-K · filed 2014-03-06 | |||
| 2012-09-30 | $4.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $183.51K 10-Q · filed 2013-11-14 | |||||
| 2012-06-30 | $179.22K 10-Q · filed 2013-08-13 | ||||||
| 2011-12-31 | $165.12K 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |